In Vivo Characterization of Human APOA5 Haplotypes
Increased plasma triglycerides concentrations are an independent risk factor for cardiovascular disease. Numerous studies support a reproducible genetic association between two minor haplotypes in the human apolipoprotein A5 gene (APOA5) and increased plasma triglyceride concentrations. We thus sought to investigate the effect of these minor haplotypes (APOA5*2 and APOA5*3) on ApoAV plasma levels through the precise insertion of single-copy intact APOA5 haplotypes at a targeted location in the mouse genome. While we found no difference in the amount of human plasma ApoAV in mice containing the common APOA5*1 and minor APOA5*2 haplotype, the introduction of the single APOA5*3 defining allele (19W) resulted in 3-fold lower ApoAV plasma levels consistent with existing genetic association studies. These results indicate that S19W polymorphism is likely to be functional and explain the strong association of this variant with plasma triglycerides supporting the value of sensitive in vivo assays to define the functional nature of human haplotypes.
- Research Organization:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Director, Office of Science; National Institutes ofHealth
- DOE Contract Number:
- DE-AC02-05CH11231; NIH:RHL071954A
- OSTI ID:
- 928488
- Report Number(s):
- LBNL-61860; GNMCEP; R&D Project: GHRUB4; BnR: 400412000; TRN: US200815%%347
- Journal Information:
- Genomics, Vol. 90, Issue 6; Related Information: Journal Publication Date: 12/2007; ISSN 0888-7543
- Country of Publication:
- United States
- Language:
- English
Similar Records
Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons
Independent effects of apolipoprotein AV and apolipoprotein CIII on plasma triglyceride concentrations